GEODE CAPITAL MANAGEMENT, LLC

Position in SILO — Silo Pharma, Inc.

CIK 1214717 BOSTON, MA

Position in SILO

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$64,810

+$33,223 QoQ

Shares Held

180,031

+93.8% QoQ

Ownership

1.11%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $18,550,967,073 across 528 Biotechnology names. SILO ranks #474 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	6,139,621	$2,741,586,360
2	REGN	Regeneron Pharmaceuticals, Inc.	2,607,732	$2,014,838,051
3	ALNY	Alnylam Pharmaceuticals, Inc.	2,660,385	$880,241,584
4	INSM	INSMED Inc	4,450,389	$727,727,608
5	MRNA	Moderna, Inc.	9,435,132	$479,304,705
6	INCY	Incyte Corp	4,703,184	$442,663,677
7	RPRX	Royalty Pharma plc	7,869,632	$377,506,246
8	BBIO	BridgeBio Pharma, Inc.	4,918,030	$365,212,906

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$64,810	180,031	+93.8%	Shares	Defined	2026-05-15
2025-12-31	$31,587	92,905	+134.6%	Shares	Defined	2026-02-09
2025-09-30	$27,320	39,596	+0.7%	Shares	Defined	2025-11-12
2025-06-30	$24,762	39,307	-11.6%	Shares	Defined	2025-08-08
2025-03-31	$52,049	44,487	+27.3%	Shares	Defined	2025-05-13
2024-12-31	$31,103	34,948	+13.6%	Shares	Defined	2025-02-12
2024-09-30	$33,837	30,761	+90.1%	Shares	Defined	2024-11-12
2024-06-30	$16,179	16,179	0.0%	Shares	Defined	2024-08-09
2024-03-31	$31,549	16,179	0.0%	Shares	Defined	2024-05-13
2023-12-31	$23,297	16,179	0.0%	Shares	Defined	2024-02-13
2023-09-30	$27,018	16,179	-34.1%	Shares	Defined	2023-11-13
2023-06-30	$50,311	24,542	0.0%	Shares	Defined	2023-08-11
2023-03-31	$51,538	24,542	—	Shares	Defined	2023-05-15
No filing history on record for this holder in this stock.